boston scientific corp
(BSX:New York Consolidated)
Transactions by BOSTON SCIENTIFIC CORP (BSX) in the last 6 months
Boston Scientific Corporation (NYSE:BSX) signed an agreement to acquire Xlumena, Inc. from Ascent Biomedical Ventures, Charter Life Sciences, Western Technology Investment and others for $75 million on April 1, 2015. The agreement comprises of an upfront payment of $62.5 million, an additional payment of $12.5 million upon FDA clearance of the HOT AXIOS product and further sales-based milestones based on sales achieved through 2018. The transaction is expected to close ...
Charter Life Sciences
Third Point LLC
Western Technology Investment
InterVene, Inc. announced that it will receive $7,215,000 in a round of funding on March 16, 2015. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
As of March 12, 2015, the company has received $5,923,731 from 52 investors in its first tranche of series A round led by Boston Scientific Corporation. The transaction included participation from members of North Texas Angels Network, ...
Green Park & Golf Ventures LLC
Boston Scientific Corporation (NYSE:BSX) agreed to acquire Men’s Health and Prostate Health Businesses from American Medical Systems Holdings Inc. for $1.7 billion on March 2, 2015. The purchase price comprises of $1.6 billion, payable in cash at closing and additional $50 million may be payable in 2017 depending on product revenue milestones of the acquired business during calendar year 2016. Boston Scientific plans to finance the transaction by issuance of $1.6 billion ...
|Astellas Pharma Inc||¥1,755 JPY||+9.00|
|Becton Dickinson and Co||$141.65 USD||-0.13|
|Olympus Corp||¥4,245 JPY||+15.00|
|St Jude Medical Inc||$73.07 USD||+0.22|
|Zimmer Biomet Holdings Inc||$109.23 USD||-0.06|
|View Industry Companies|